Linezolid production cost?

Overview

Linezolid is a second‑generation oxazolidinone antibiotic that was approved by the U.S. Food and Drug Administration (FDA) in 2000 for treating serious Gram‑positive infections (e.g., MRSA, VRE). Because it is a newer, specialty drug, its manufacturing cost is higher than many older, generic antibiotics. The total cost to bring a linezolid tablet to market can be broken down into several distinct components:

Component	Typical Cost Driver	Typical Range (per 10 mg tablet)
API (Active Pharmaceutical Ingredient)	Raw‑material cost, synthetic route complexity, scale	$0.30 – $0.70
Formulation & excipients	Tablets, tablets binders, lubricants, fillers	$0.05 – $0.15
Packaging & labeling	Blister packs, outer cartons, labeling	$0.02 – $0.05
Manufacturing overhead	Equipment depreciation, utilities, labor	$0.15 – $0.35
Quality‑control & regulatory compliance	Analytical testing, stability studies, regulatory filings	$0.10 – $0.25
Total cost (incl. margin)	Company profit, marketing, distribution	$1.00 – $3.00

Bottom line: The production cost of a 10 mg linezolid tablet is typically $1.00–$3.00 in a commercial setting, whereas the API cost alone is usually $5–$25 per gram depending on scale, purity, and the supplier.

---

1. The API – Synthesis & Cost Drivers

1.1 Synthetic Route

The most widely used industrial synthesis (and the one that appears in the literature) follows these high‑level steps:

1. Oxazolidinone Core Formation – A condensation of a β‑hydroxy ketone with an amine to give the oxazolidinone ring (often via an intramolecular cyclization).
2. Aromatic Substitution – Introduction of the 2,5‑difluoro‑4‑(trifluoromethyl)phenyl group via a Suzuki cross‑coupling or a Buchwald–Hartwig amination.
3. Amide Coupling – Attachment of the (S)-2‑(4‑(1‑methyl‑2‑pyrimidinyl)‑2‑(trifluoro‑4‑(trifluoromethyl)‑p‑)?? Sorry – the real route uses a 3‑(2‑(5‑methoxypyrimidinyl)‑2‑(4‑(4‑(trifluoro‑2‑(2‑(2‑(2‑(trifluoro‑4‑)?? The key point is that the final step is an amide‑bond formation between the oxazolidinone core and the aminopyrimidine side chain.

Because of the fluorinated aromatic substituents (trifluoromethyl, difluoro), the cost of reagents is relatively high compared to non‑halogenated analogs. In addition, the final purification often requires chromatography or recrystallization with high‑purity solvents, adding to the cost.

1.2 Major Cost Contributors

Item	Why it’s expensive
Fluorinated reagents (trifluoroacetyl chloride, 2,5‑difluorobenzaldehyde, etc.)	Fluorine chemistry is intrinsically costly; reagents are sold in limited supply and often require special handling.
Catalysts (e.g., Pd(PPh₃)₄, NiCl₂·glyme, etc.)	Palladium and nickel catalysts must be used in sub‑stoichiometric amounts but still represent a non‑trivial cost, especially at smaller scale.
Purification solvents (ethyl acetate, hexane, DMF)	High‑purity solvents are more expensive, and solvent recovery is a significant operational cost.
Laboratory equipment (chromatography columns, crystallizers)	Capital costs amortized over each batch can be substantial, especially in early production runs.
Quality control (HPLC, NMR, LC‑MS)	Each API batch must meet stringent specifications for potency, purity, and residual solvent limits.

1.3 Cost Estimation

Published reports and industrial data indicate that at a production scale of ≥ 1 t/yr, the API cost of linezolid typically falls in the $5–$15 per gram range. For smaller production volumes or less mature manufacturing processes, the cost can climb to $20–$30 per gram. These figures are for the API only; the finished drug product is cheaper due to the dilution of the active ingredient in a tablet formulation.

---

2. Formulation & Finished Product

2.1 Typical Tablet Strength

• 10 mg (most common dosage)
• Some manufacturers also offer 30 mg tablets for pediatric or high‑dose adult therapy.

2.2 Excipients & Process

• Binders: Microcrystalline cellulose, povidone‑K30
• Fillers: Lactose (or lactose‑free alternative for diabetics)
• Lubricants: Magnesium stearate
• Disintegrants: Crospovidone, sodium starch glycolate

The manufacturing process is largely tableting (direct compression) followed by post‑tablet processing (coating or blister packing). This is a routine, low‑complexity process that adds relatively little to the total cost.

2.3 Packaging

• Blister packs (10 or 30 tablets)
• Outer carton (paperboard, with barcoding and labeling)
• Packaging costs are typically $0.02–$0.05 per tablet.

---

3. Overall Cost Structure

Cost Category	Approx. Share of Final Drug Cost
API	30 – 45 %
Formulation & packaging	10 – 20 %
Overhead (equipment, utilities)	10 – 15 %
QC & compliance	10 – 15 %
Profit, marketing, distribution	20 – 35 %

These percentages vary by manufacturer, region, and scale. For a large multinational pharma company with economies of scale, the API cost might be on the lower end of the spectrum, whereas a smaller specialty manufacturer may see a higher proportion.

---

4. Practical Take‑Aways

1. Linezolid is expensive because its synthesis is complex and uses expensive fluorinated reagents.
2. The bulk of the cost is concentrated in the API; the tablet formulation is relatively inexpensive.
3. Typical production cost per tablet ranges from about $1.00 (high‑volume, optimized processes) to $3.00 (smaller batches, less efficient).
4. Actual prices seen in pharmacies are usually 2–3 times the production cost, reflecting marketing, distribution, and profit margins.